Arsenale Bioyards has successfully completed its $10 million seed funding round and its innovative approach to biomanufacturing. It highlights the company’s end-to-end platform that integrates advanced bioreactors with AI-driven software, aiming to reduce production costs by up to 90%. It explains Bioyards’ modular concept, data-first approach and potential impact on various industries. It concludes by mentioning the expertise of the founding team and the company’s potential to transform biomanufacturing into an investable asset class.
Source: Arsenale Bioyards secures $10m to lower biomanufacturing costs | The Cell Base